Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection

ClinicalTrials.gov ID: NCT04359680

Public ClinicalTrials.gov record NCT04359680. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 2:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection

Study identification

NCT ID
NCT04359680
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Romark Laboratories L.C.
Industry
Enrollment
1,407 participants

Conditions and interventions

Interventions

Drug · Dietary Supplement

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 13, 2020 (Actual)
Primary completion
Apr 7, 2021 (Actual)
Completion
Apr 7, 2021 (Actual)
Last update posted
Jun 26, 2024

2020 – 2021

United States locations

U.S. sites
26
U.S. states
10
U.S. cities
24
Facility City State ZIP Site status
HealthStar Research LLC Hot Springs Arkansas 71913 —
So Cal Clinical Research Huntington Beach California 92647 —
Long Beach Clinical Trials, LLC Long Beach California 90806 —
Meris Clinical Research Brandon Florida 33511 —
Invesclinica US LLC Fort Lauderdale Florida 33308 —
The Chappel Group Research Kissimmee Florida 34744 —
New Horizon Research Center Miami Florida 33165 —
Clinical Neuroscience Solutions, Inc. Orlando Florida 32801 —
DMI Research Pinellas Park Florida 33782 —
Tampa General Hospital Tampa Florida 33606 —
Chicago Clinical Research Institute, Inc. Chicago Illinois 60607 —
Chicago Medical Research Institute, Inc. Chicago Illinois 60607 —
Quad Clinical Research Chicago Illinois 60643 —
Chicago Medical Research, LLC Hazel Crest Illinois 60429 —
Centex Studies, Inc. Lake Charles Louisiana 70601 —
Vida Clinical Studies Dearborn Michigan 48124 —
Beacom Family Health Connection Fremont Nebraska 68025 —
North Jersey Community Research Initiative Newark New Jersey 07103 —
Integrative Clinical Trials LLC Brooklyn New York 11229 —
The New York Center for Travel and Tropical Medicine New York New York 10022 —
RH Medical Urgent Care Professional PLLC The Bronx New York 10456 —
Centex Studies, Inc. Houston Texas 77058 —
SMS Clinical Research LLC Mesquite Texas 75149 —
LinQ Research LLC Pearland Texas 77584 —
Rio Grande Valley Clinical Research Institute Pharr Texas 78577 —
BFHC Research San Antonio Texas 78249 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04359680, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 26, 2024 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04359680 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →